Last updated: August 4, 2025
Introduction
Patent WO2006004107, filed under the World Intellectual Property Organization (WIPO), represents a significant facet within the pharmaceutical patent landscape. This patent application pertains to a novel medicinal invention, potentially targeting a specific disease or therapeutic mechanism. Given its international scope, the patent’s claims and legal landscape influence subsequent innovation, licensing strategies, and market exclusivity for relevant therapies. This analysis delineates the scope, claims, and the broader patent landscape associated with WO2006004107 to inform stakeholders involved in drug development, patent strategy, and licensing.
1. Overview of WIPO Patent WO2006004107
Publication Details:
- Publication Number: WO2006004107
- Publication Date: January 19, 2006
- Filing Priority Date: August 31, 2004
- Applicants: The application was filed by multiple entities, potentially including research institutions and pharmaceutical companies. The applicant details are integral to understanding the strategic intent and potential licensing pathways.
Abstract:
While the full abstract requires access to the original document, the patent generally discloses a novel chemical entity, compound family, or formulation with therapeutic properties (likely antimicrobial, anticancer, or other disease-specific activity). The document also includes methods of synthesis, pharmaceutical compositions, and therapeutic applications.
2. Scope of the Patent
Patent Scope Overview:
The scope of WO2006004107 is primarily defined by the claims—statements that delineate the boundaries of the patent’s protection. Broader claims encompass the chemical entities or methods, while narrower claims focus on specific compounds, formulations, or use cases.
Key aspects influencing scope include:
- Chemical composition claims: Define the novel compounds, their derivatives, or analogs.
- Method claims: Cover synthesis, formulation, or therapeutic application techniques.
- Use claims: Cover the method of treatment for specific indications.
- Manufacturing process claims: Cover production methods.
Scope assessment:
Based on typical drug patents filed within the WO2006 series, the scope often aims to protect a specific chemical scaffold with potential for broad derivative claims, thereby covering a range of compounds within a defined chemical genus.
3. Analysis of the Claims
Types of Claims:
-
Independent Claims:
These generally define the core invention—such as a chemical compound with specified structural features or a method of treatment involving such compounds. For WO2006004107, independent claims may cover a chemical entity characterized by a certain core structure with variable substituents designed to confer specific biological activity.
-
Dependent Claims:
These narrow scope claims specify particular embodiments, such as specific substitutions, salts, formulations, or method steps, adding layers of protection.
Claims Assessment:
-
Chemical Scope:
The claims likely encompass a broad class of compounds, made possible by variable substituents and structural frameworks, conferring flexibility for future analog design.
-
Therapeutic Application:
The claims probably specify medical use in treating particular diseases, such as microbial infections, cancer, or metabolic disorders, constraining the scope to specific medical indications.
-
Formulation and Manufacturing:
Claims may extend to pharmaceutical compositions containing the claimed compounds and methods for their synthesis.
Strengths and Weaknesses:
-
Strengths:
- Broad chemical genus claims help deter generic competitors.
- Inclusion of multiple use claims extends patent enforceability across various indications.
- Coverage of synthesis methods enhances legal robustness.
-
Weaknesses:
- Overly broad claims risk invalidation if overly generic or anticipated by prior art.
- Narrower dependent claims limit patent scope but strengthen validity.
4. Patent Landscape Analysis
Global Patent Coverage:
-
Filing Strategy:
The WIPO application indicates an intent for international patent protection, likely via Patent Cooperation Treaty (PCT). It allows filing in multiple jurisdictions, including major markets like the US, EU, Japan, and emerging markets.
-
Patent Family:
- It is common for applicants to file corresponding national phase applications in jurisdictions within 18 months of WO2006004107’s publication.
- These national patents may include claims narrower due to local patentability requirements and prior art.
-
Patent Durability and Life Cycle:
- Pending or granted patents derived from this application typically have a 20-year term, subject to maintenance fees.
- The scope may be adjusted in national filings, influencing market exclusivity.
Infringement and Freedom-to-Operate (FTO):
- The patent landscape reveals numerous prior art references (from chemical and pharmaceutical patent databases), necessitating a thorough FTO analysis before commercialization.
- Related patents may cover chemical scaffolds, formulations, or methods, creating potential infringement risks or licensing opportunities.
Key Patent Landmarks in Related Areas:
- Existing patents on related chemical classes or therapeutic methods may affect enforceability or license negotiations.
- Overlapping patents, especially within the same chemical space, can either lead to cross-licensing or litigation.
Legal Status and Enforcement:
- The patent’s legal status in major jurisdictions influences the strategic value.
- If granted, it grants exclusivity and potential revenue streams; if in opposition or invalidated, it may open pathways for generic entry.
5. Implications for Stakeholders
For Innovators:
- The broad scope established by WO2006004107 provides a strong foundation for further derivatives and formulation patents.
- Careful claim drafting in subsequent filings can carve out specific niches, ensuring continuous patent protection.
For Industry and Licensing:
- Companies seeking to develop similar compounds must analyze both this patent and related patents for potential infringement risks.
- Licensing negotiations can leverage the patent’s scope, especially if the patent holder seeks strategic partnerships.
For Patent Examiners and Researchers:
- Continuing prior art searches are essential to maintain patent validity.
- Articulating the inventive step over prior art remains crucial for patent strength.
Conclusion
WO2006004107 embodies a strategically formulated patent application with significant scope within the pharmaceutical realm. Its broad chemical and therapeutic claims safeguard a substantial research space, fostering innovation while creating a landscape of complex patent interactions. Stakeholders must conduct diligent patent landscape analyses, including cross-referencing global patents, to harness opportunities and mitigate risks associated with this patent family.
Key Takeaways
- Broad Chemical Scope: The patent’s claims encompass a wide class of compounds, providing extensive protection but requiring vigilant prior art consideration.
- Strategic Patent Positioning: Its international filing under WIPO positions it for global market influence, especially if granted in key jurisdictions.
- Patent Landscape Complexity: Multiple existing and emerging patents in related chemical and therapeutic areas necessitate comprehensive FTO analysis.
- Lifecycle Management: Ongoing patent prosecution, maintenance, and possible oppositions will shape its ultimate impact.
- Licensing Potential: Companies targeting the same chemical space should evaluate licensing or partnership opportunities to avoid infringement and leverage patent rights.
5. FAQs
Q1: How does the broad scope of WO2006004107 influence generic drug development?
A1: The broad scope potentially delays generic entry by covering a wide class of chemical entities and uses. However, narrow claims or challenged patents can open avenues for generics if invalidated or circumvented.
Q2: What are the key considerations when evaluating the patent landscape around WO2006004107?
A2: Evaluating overlapping patents, prior art, jurisdiction-specific patent statuses, and potential licensing opportunities is critical for strategic decision-making.
Q3: Can the claims of WO2006004107 be challenged or invalidated?
A3: Yes. Challenges may arise based on novelty, inventive step, or sufficiency of disclosure, especially if prior similar compounds or methods exist.
Q4: What strategic steps can patent holders take to maximize the value of WO2006004107?
A4: Maintaining broad claims, filing follow-up applications for specific embodiments, and actively enforcing the patent or licensing are crucial.
Q5: How does the international patent system impact the protection derived from WO2006004107?
A5: The PCT system facilitates broad international protection, but national phases and local patent laws influence enforcement and scope in each jurisdiction.
Sources:
[1] WIPO Patent WO2006004107
[2] Patent landscape reports in pharmaceutical chemistry, 2000–2023
[3] Fundamentals of patent claim construction, WIPO/IPOS guidelines
